Cybin (HELP) Net Cash Flow (2020 - 2025)
Cybin (HELP) reported Net Cash Flow of -$847450.4 for Q1 2025, down 100.67% on a YoY basis from $126.1 million in Q1 2024, and up 95.71% quarter-over-quarter from -$19.8 million in Q4 2024.
Cybin (HELP) Net Cash Flow (2020 - 2025) Analysis & Trends
Cybin has reported Net Cash Flow for 6 years, with the latest figure at -$847450.4 in Q1 2025.
- For the quarter ending Q1 2025, Net Cash Flow fell 100.67% year-over-year to -$847450.4; the trailing twelve-month figure through Jun 2025 stood at -$40.1 million (down 131.34% YoY), and the FY2025 full-year result was -$59.8 million, down 141.82% from the prior year.
- Net Cash Flow for Q1 2025 stood at -$847450.4, up from -$19.8 million in the prior quarter.
- The five-year high for Net Cash Flow was $126.1 million in Q1 2024, with the low at -$20.2 million in Q2 2024.
- Historically, Net Cash Flow has averaged $5.0 million across 5 years, with a median of -$5.5 million in 2022.
- Annual changes were most pronounced in 2021 — Net Cash Flow jumped 655.45% — and 2024, when it plunged 401.31%.
- Cybin's Net Cash Flow stood at -$9.2 million in 2021, then soared by 39.7% to -$5.5 million in 2022, then surged by 380.59% to $15.5 million in 2023, then plunged by 227.14% to -$19.8 million in 2024, then surged by 95.71% to -$847450.4 in 2025.
- The last three Net Cash Flow figures came in at -$847450.4 (Q1 2025), -$19.8 million (Q4 2024), and -$19.5 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -847,450.43 |
| Mar 31, 2025 | -847,450.43 |
| Dec 31, 2024 | -19.76 Mn |
| Dec 31, 2024 | -19.76 Mn |
| Sep 30, 2024 | -19.47 Mn |
| Sep 30, 2024 | -19.47 Mn |
| Jun 30, 2024 | -20.24 Mn |
| Jun 30, 2024 | -20.24 Mn |
| Mar 31, 2024 | 126.11 Mn |
| Mar 31, 2024 | 126.11 Mn |
| Dec 31, 2023 | 15.54 Mn |
| Dec 31, 2023 | 15.54 Mn |
| Sep 30, 2023 | 6.46 Mn |
| Sep 30, 2023 | 6.46 Mn |
| Jun 30, 2023 | -5.39 Mn |
| Jun 30, 2023 | -5.39 Mn |
| Feb 28, 2023 | -14.65 Mn |
| Feb 28, 2023 | -14.65 Mn |
| Dec 31, 2022 | -5.54 Mn |
| Dec 31, 2022 | -5.54 Mn |